MON 2011 - Slide 30 - S. Faithfull / D. Papageorgiou - Case presentations: Post-therapy effects: metabolic, skeletal and neurological effects

•

0 likes•201 views

European School of Oncology

Invisible symptoms ,[object Object],[object Object],[object Object],[object Object],Brown J et al. (2010) BJUI 1042-1043 De Haas et al. 2010 Lancet Oncology Hamilton EJ et al. (2010) J Clin Endo. Metab . (12 E4560-E463

Metabolic syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],Lockwood G et al. 2009 Cancer 115 2388-99

Clinical issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wadhwa VK et al. (2009) BJUI 104 800-805 Gralow JR et al 2009, NCCN Task force report: bone health in cancer care J Nati Comp Canc Netw. Suppl 3 1-32

Health promotion Hadji P, et al. Ann Oncol (2008);19:1407–16 Yamamoto DS Viale PH (2009) Clinical Journal of Oncology Nursing 13 (5) E18-E29 . Activity 20-50% Chemoprevention Nutritional advice Lifestyle advice

Prevention and management Treatment algorithm

Using effectively what we already know ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Greenfield D et al. (2009) Follow up for cancer survivors: the views of clinicians BJC , 1010 568-574 Khan, N et al (2010) Quality of care for chronic diseases in a British cohort of long term cancer Annals of Family Med . 8 (5) 418-424

What's hot

Research Biopsies and Translational Research - Dr. Jennifer WargoMelanoma Research Foundation

Localized Treatment for Metastatic DiseaseMelanoma Research Foundation

HSR ESMO posterShaidah Deghan, MSc., MD(C)

Concurrent versus sequential CTRT in lung cancerAjeet Gandhi

Leukemia TherapySam W. Lee

After Starting Therapydemiss

Chapter 26 chemoprevention of cancerNilesh Kucha

Predictors of imatinib failure in cml by prof. abinyaKesho Conference

The Efficacy and Prescription of NMES in Adult Cancer Survivors - a systemati...CATCH - eHealth for cancer patients

The B-AHEAD 2 Trial: Randomised controlled trial of intermittent versus conti...World Cancer Research Fund International

CRPC managementMohamed Abdulla

Local Therapies for Uveal Melanoma Liver MetastasesMelanoma Research Foundation

ABC1 - L. Fallowfield - Differencies in side effects assessment among doctors...European School of Oncology

8000 0830 kian aan gap overviewspa718

How to Approach Systemic Treatment for Metastatic DiseaseMelanoma Research Foundation

Familial predisposition for colorectal cancers: Who to screen?OSUCCC - James

Jco 2006-demark-wahnefried-3517-8ANGELAnerja

01&02 rencontres biomédicale Christian BoitardAssociation LIR

Prostate cancer-double-vision-but-solitary-lesionAnnex Publishers

Type 2 Diabetes and CancerPrimary Care Diabetes Europe

What's hot (20)

Research Biopsies and Translational Research - Dr. Jennifer Wargo

Localized Treatment for Metastatic Disease

HSR ESMO poster

Concurrent versus sequential CTRT in lung cancer

Leukemia Therapy

After Starting Therapy

Chapter 26 chemoprevention of cancer

Predictors of imatinib failure in cml by prof. abinya

The Efficacy and Prescription of NMES in Adult Cancer Survivors - a systemati...

The B-AHEAD 2 Trial: Randomised controlled trial of intermittent versus conti...

CRPC management

Local Therapies for Uveal Melanoma Liver Metastases

ABC1 - L. Fallowfield - Differencies in side effects assessment among doctors...

8000 0830 kian aan gap overview

How to Approach Systemic Treatment for Metastatic Disease

Familial predisposition for colorectal cancers: Who to screen?

Jco 2006-demark-wahnefried-3517-8

01&02 rencontres biomédicale Christian Boitard

Prostate cancer-double-vision-but-solitary-lesion

Type 2 Diabetes and Cancer

Similar to MON 2011 - Slide 30 - S. Faithfull / D. Papageorgiou - Case presentations: Post-therapy effects: metabolic, skeletal and neurological effects

MON 2011 - Slide 27 - S. Faithfull - Spotlight session - SurvivorshipEuropean School of Oncology

NY Prostate Cancer Conference - F. Saad - Session 7: Predicting toxicity afte...European School of Oncology

Breast cancer a focus on bone health integrityMohamed Abdulla

Management of colorectal cancer Mohamed Abdulla

Kiow 11 2017 metastatic colon cancer from bench to clinicMohamed Abdulla

Exeter exercise and cancer oct 13BenJane

DrLam HighRiskProstateCancer(Azure)PCRI_2012conf

Hormone replacement therapyProf. Shad Salim Akhtar

ECCLU 2011 - B. Tombal - Side-effects of anti-androgen therapyEuropean School of Oncology

orthopedics.pdfdrArisantyNurSetiaRe

A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology

UROLOGIC NURSING November-December 2019 Volume 39 Number.docxgibbonshay

UROLOGIC NURSING November-December 2019 Volume 39 Number.docxjessiehampson

Understanding Osteoporosissgorthosurgeon

Treatment Duration Aderence Compliance and Concordance and Management Of Oste...National Osteoporosis Society

Genetic Edge Compounds ADVANCED NUTRITION FOR MUSCLE HEALTH.pptxGenetic Edge Compounds

Radiation Therapy: Nutritional Strategies to Improve OutcomesJeanne M Wallace PhD

I. Tannock - New developments in the systemic treatment of advanced prostate ...European School of Oncology

Trattamenti ipofrazionati ed ipofrazionati-accelerati: nuove possibilità di p...Gemelli Advanced Radiation Therapy

Drug-induced Osteoporosisdemiss

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology

G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology

W. Hassen - Bladder cancer - GuidelinesEuropean School of Oncology

A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology

H. Khaled - Bladder cancer - State of the artEuropean School of Oncology

A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology

1 azimEuropean School of Oncology

H. Azim - Lymphomas - State of the artEuropean School of Oncology

S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology

A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology

J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology

A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology

V. Kesic - Cervical cancer - State of the art European School of Oncology

T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology

N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology

S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology

S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology

G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology

A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology

J.B. Vermorken - Head and neck - State of the artEuropean School of Oncology

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...

G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...

W. Hassen - Bladder cancer - Guidelines

A. Stathis - New drugs in the treatment of lymphomas

H. Khaled - Bladder cancer - State of the art

A. Stathis - Lymphomas - New drugs in the treatment of lymphomas

1 azim

H. Azim - Lymphomas - State of the art

S. Khleif - Ovarian cancer - General lecture on vaccine

A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...

J.B. Vermorken - Ovarian cancer - State of the art

A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...

V. Kesic - Cervical cancer - State of the art

T. Cufer - Breast cancer - State of the art for advanced breast cancer

N. El Saghir - Breast cancer - State of the art for early breast cancer

S. Cascinu - Liver/Hepatobiliary - State of the art

S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...

G. Pentheroudakis - Colorectal cancer - State of the art

A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...

J.B. Vermorken - Head and neck - State of the art